(live-PR.com) - Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a report on cardiovascular drug delivery markets which provides forecasts to 2017.

“Cardiovascular Drug Delivery: Technologies, markets and companies” which is available at http://tinyurl.com/535nh4 forecasts on the basis of epidemiology and total markets for cardiovascular therapeutics.

The study takes into consideration the anticipated advances and availability of various technologies, particularly drug delivery devices in the future. Markets for drug-eluting stents are calculated separately and the role of drug delivery in developing cardiovascular markets is defined, even as unmet needs in cardiovascular drug delivery technologies are identified.
This 254-page report provides key information on the 84 companies that either develop technologies for drug delivery to the cardiovascular system or products using these technologies. It contains 68 collaborations between companies which are tabulated.
Authors of the report say that advances in molecular pathophysiology of cardiovascular diseases have brought gene therapy within the realm of possibility as a novel approach to treatment of these diseases.
“Cardiovascular Drug Delivery: Technologies, markets and companies” is available in pdf format from Piribo.
For more information, go to:
http://www.piribo.com/publications/drug_delivery/cardiovascular_drug_delivery.html

Piribo product ID: JAI004

About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 10,000 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.